학술논문

Bevacizumab as a last-line treatment for glioblastoma following failure of radiotherapy, temozolomide and lomustine
Document Type
Article
Source
In: Oncology Letters. (Oncology Letters, 2017, 14(1):1141-1146)
Subject
Language
English
ISSN
17921082
17921074